Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemo-Reference-Cited by-同舟云学术

Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemo

Published:2013-01 Issue:1 Volume:11 Page:177-179
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:

Author:

AGENO W.,CROWTHER M.,BAGLIN T.,FALANGA A.,BULLER H.,PALARETI G.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12038/fullpdf

Reference9 articles.

1. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study;Heeringa;Eur Heart J,2006

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

4. Oral Anticoagulant Therapy. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Ageno;Chest,2012

5. European Medicines Agency Pradaxa. Summary of Product Characteristics http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000829/WC500041059.pdf

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2021-12-22

2. Appropriateness of Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: Insights From the Veterans Health Administration;Journal of Pharmacy Practice;2019-02-21

3. The use of direct oral anticoagulants in the treatment of acute venous thromboembolism in cancer patients;Expert Review of Hematology;2018-06-01

4. Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants;Expert Review of Hematology;2017-07-31

5. Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism;Pharmacological Research;2017-04